Pentwater Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-500,000
Closed -$19.7M 161
2023
Q2
$19.7M Buy
+500,000
New +$17.6M 0.14% 51
2014
Q2
Sell
-40,000
Closed -$1.43M 169
2014
Q1
$1.43M Buy
+40,000
New +$1.35M 0.04% 104

Pentwater Capital Management's ISEE Position: Q3 2023 in Review

Pentwater Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 500,000 shares — an estimated $19.7M sold.

Pentwater Capital Management first reported a position in ISEE in Q1 2014 and held it in 2 quarters. The position peaked at $19.7M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Pentwater Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Pentwater Capital Management sold 500,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $19.7M.
  • Pentwater Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 2 quarters.
  • Pentwater Capital Management's IVERIC bio, Inc. Common Stock position peaked at $19.7M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Pentwater Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.